Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Overview of attention for article published in Lancet Neurology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#32 of 4,643)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 70 news outlets
blogs: 3 blogs
policy: 4 policy sources
twitter: 219 X users
patent: 1 patent

facebook: 3 Facebook pages
wikipedia: 4 Wikipedia pages
reddit: 2 Redditors
guideline: 5 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 6594 Mendeley

So far, Altmetric has seen 81 news stories from 70 outlets.

Schlaganfall und Stammzellen

Spektrum, 23 Dec 2025

23. Dez. 2025 Von Ruzica Sedic Lesedauer ca. 12 Minuten Sehstörungen, Sprach- und Sprachverständnisstörungen, Lähmungen und…

¿Investigamos lo que realmente importa? Una brecha incómoda en la ciencia médica del envejecimiento

The Conversation, 09 Nov 2025

Últimamente los hospitales están repletos de pacientes que superan los 85 años de edad.

Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke

AP News, 31 Jul 2025

TACOMA, Wash., July 31, 2025 /PRNewswire/ -- Revalesio, a clinical-stage biopharmaceutical company developing treatments for…

Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke

Newswise, 31 Jul 2025

Newswise — TACOMA, Wash., July 31, 2025 -- Revalesio, a clinical-stage biopharmaceutical company developing treatments for…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 77 additional news stories.